All In MedTech

Device Trial Radar · NCT06863675

Highly Aspherical Lenslet (HAL) and Binocular Vision (BV) Disorders [HALT X(T) Study]

Last checked: Nov 19, 2026Latest source record: Mar 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Jun 1, 2025

Primary completion

Jun 30, 2028

Study completion Jun 30, 2030

Sponsor

Lead sponsor
Singapore National Eye CentreGovernment (non-federal)
Sponsor type
Government (non-federal)
First posted
Mar 7, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 5 years, up to 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Assess the effect and changes of eye misalignment (strabismus) with myopia control glasses Assess the efficacy of myopia control glasses on childhood myopia progression in children with strabismus due to the uncertainty clinicians face when prescribing myopia control glasses to these strabismic children

Conditions

  • Myopia
  • Strabismus

Interventions

  • HAL lenses for children with strabismusDevice

    It has been shown that peripheral segmented defocus spectacles can slow myopia progression. The Essilor® Stellest™ lens has been designed with an exclusive and pioneering technology called HALT (Highly Aspherical Lenslet Target). The HALT technology is made of a constellation of 1,021 invisible lenslets. This constellation creates a signal in front of the retina that acts as a shield against eye elongation and, therefore, myopia progression. Studies suggest that children are tolerable against these glasses, and the lenses can slow down myopia progression by 67% on average, compared to single vision lenses, when worn 12 hours a day. It can be considered as one of the best available myopia control spectacle lens designs, being superior to progressive addition and bifocal lenses.

  • SVL for children with strabismusDevice

    SVL for children with strabismus

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To assess the efficacy of HAL lenses in childhood myopia control in children with strabismus and nystagmusTime frame: 2 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Singapore National Eye Centre

    Singapore, Singapore

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.